Heidi Overton faces tough Senate hearing over FDA nomination

Heidi Overton: Dr. Heidi Overton is a preventive medicine physician serving as a top domestic policy adviser in the White House and a former chief policy adviser at a conservative think tank. She was nominated by President Trump in August 2026 to lead the FDA, making her the first openly anti-mifepristone nominee for the role with a background more political than prior commissioners. In the news, she faces Senate scrutiny over her role in developing a recent executive order on childhood vaccines and concerns about her limited management experience. Trump Administration: The Trump Administration refers to the current U.S. executive branch under President Donald Trump, focused on 'America First' health policies including revisions to vaccine recommendations. It nominated Heidi Overton, a loyal White House aide, to head the FDA and supported her during the signing of a vaccine-related executive order. In the news, the administration's pick is set for a challenging confirmation hearing amid senatorial concerns over vaccine policies and nominee qualifications. Senate Hearing: Overton appeared before the Senate HELP Committee for her FDA confirmation hearing, facing questions on vaccines, abortion pills, and her policy background. Nominee Background: Overton, a physician and White House adviser with prior roles in both Trump administrations, has drawn attention for her political alignment over extensive agency management experience. Vaccine Executive Order: The administration issued an executive order last month directing changes to childhood vaccine recommendations, which Overton helped develop and publicly supported.